TRAF3IP2 and cancer: This finding is consistent with prior reports and the suggested outcome of BBC3 induction leading to the sensitization of cancer cells to cisplatin [67,68,69], we find that aCT1 combined with cisplatin has a greater effect than either single agent on its own.